Assignee
LUTRIS PHARMA LTD
IL·5 granted patents·3 pending applications·5 citations·filing 2018–2023
Top patents by PatentIndex Score
8 records- 0181US10927112B2BRaf inhibitors and use thereof for treatment of cutaneous reactionsLUTRIS PHARMA LTD·Filed 2019·Granted Feb 23, 2021·2 cites·24 claims
- 0280US11339163B2BRaf inhibitors and use thereof for treatment of cutaneous reactionsLUTRIS PHARMA LTD·Filed 2020·Granted May 24, 2022·1 cites·20 claims
- 0377US11197861B2Methods of screening BRaf inhibitors for treating cutaneous reactionsLUTRIS PHARMA LTD·Filed 2020·Granted Dec 14, 2021·1 cites·8 claims
- 0477US10632123B2Use of BRaf inhibitors for treating cutaneous reactionsLUTRIS PHARMA LTD·Filed 2018·Granted Apr 28, 2020·1 cites·12 claims
- 0566US2022274988A1Braf inhibitors and use thereof for treatment of cutaneous reactionsLUTRIS PHARMA LTD·Filed 2022·Application pending·0 cites
- 0661US2024122933A1Use of isoquinoline-1,5-diamines for wound healingLUTRIS PHARMA LTD·Filed 2023·Application pending·0 cites
- 0757US2023321106A1Use of topical braf inhibitor compositions for treatment of epidermal growth factor receptor downstream effectors - induced cutaneous reactionsLUTRIS PHARMA LTD·Filed 2023·Application pending·0 cites
- 0852US11439648B2Use of topical BRAF inhibitor compositions for treatment of radiation dermatitisLUTRIS PHARMA LTD·Filed 2021·Granted Sep 13, 2022·0 cites·18 claims
Join the waitlist — get patent alerts
Get an alert when LUTRIS PHARMA LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →